ABSTRACT
OBJECTIVE: The aim of this study was to analyze in a prospective cohort of hospitalized COVID-19 patients the relationship between biomarkers levels and their variation within the first 4 days since admission, and prognosis. METHODS: Prospective cohort study. Individuals with confirmed diagnosis of covid-19 admitted in our hospital were included. Blood samples were obtained systematically on days 1 and 4 of hospitalization. Levels of RCP, LDH, Ferritin and D-dimer, together with platelets, lymphocytes and neutrophils counts were measured. A combined outcome that included ICU admission and death was considered the primary outcome. Logistic regression analysis was performed. RESULTS: We included 335 patients with confirmed COVID-19. During their hospitalization, 23 (6.8%) needed ICU admission, and 10 (2.9%) died. In the multivariate analysis, a value of RCP greater than 10 mg/dl (OR 8.69, CI95% 1.45-52), an increase in RCP greater than 20% (OR 26.08, CI 95% 3.21-211.3), an increase in LDH greater than 20% (OR 6.29, CI 95% 1.84-21.44), a count of lymphocytes lower than 1500/mm3 (OR 2.74, CI 95% 1.04-7.23), a D-dimer value greater than 550 ng/ml (OR 9.8, CI 95% 1.78-53.9) and a neutrophil/lymphocyte index greater than 3(OR 4.5, CI 95% 1.43-14.19) were all associated with the primary outcome. CONCLUSIONS: Our study shows that the utilization of static and dynamic biomarkers may represent an important tool to assess prognosis of COVID-19 patients.
Subject(s)
COVID-19/diagnosis , Adult , Aged , Biomarkers/analysis , Blood Cell Count , COVID-19/mortality , Cohort Studies , Comorbidity , Critical Care/statistics & numerical data , Female , Hematologic Tests , Humans , Inpatients , Length of Stay , Male , Middle Aged , Patient Admission , Predictive Value of Tests , Prognosis , Prospective Studies , Treatment OutcomeSubject(s)
Middle Aged , Female , Humans , Carcinoma, Squamous Cell/secondary , Lung Neoplasms/pathology , Muscle Neoplasms/secondary , Carcinoma, Squamous Cell/diagnostic imaging , Fatal Outcome , Lung Neoplasms/diagnostic imaging , Magnetic Resonance Spectroscopy , Muscle Neoplasms/diagnostic imagingSubject(s)
Middle Aged , Female , Humans , Carcinoma, Squamous Cell/secondary , Lung Neoplasms/pathology , Muscle Neoplasms/secondary , Carcinoma, Squamous Cell/diagnostic imaging , Fatal Outcome , Lung Neoplasms/diagnostic imaging , Magnetic Resonance Spectroscopy , Muscle Neoplasms/diagnostic imagingABSTRACT
We describe a 26-year-old white female with a history of Raynaud phenomenon, erythema nodosum, polyarthralgias, migraine, vertigo, seizures, transient ischemic attacks, one fetal loss, and false positive VDRL, who developed milk hypertension without overt lupus nephritis. She had positive antinuclear antibodies (ANA) and double-stranded deoxyribonucleic acid (dsDNA) antibodies. The lupus anticoagulant test (LAC) and cardiolipins antibodies (aCL) were positive. She was diagnosed as having a Systemic Lupus Erythematosus-like illness (SLE-like) with 'secondary' antiphospholipid syndrome (APS). Renal spiral computed tomography (CT) with intravenous (IV) contrast showed bilateral renal artery stenosis. Anticoagulation with acenocumarol was started. She became normotensive without antihypertensive drugs five months later. A follow-up renal spiral CT showed complete recanalization of both renal arteries, making thrombosis the more likely culprit pathology in the stenosis. After two years follow up the patient is normotensive. She remains on acenocumarol.
Subject(s)
Antiphospholipid Syndrome/complications , Renal Artery Obstruction/etiology , Acenocoumarol/therapeutic use , Adult , Antibodies, Anticardiolipin/analysis , Antibodies, Antinuclear/analysis , Anticoagulants/therapeutic use , Antiphospholipid Syndrome/diagnostic imaging , Antiphospholipid Syndrome/physiopathology , DNA/immunology , Female , Humans , Hypertension/complications , Lupus Coagulation Inhibitor/analysis , Raynaud Disease/complications , Renal Artery/diagnostic imaging , Renal Artery/physiopathology , Renal Artery Obstruction/diagnostic imaging , Renal Artery Obstruction/physiopathology , Tomography, X-Ray ComputedABSTRACT
We report a case of a 35 year-old woman with idiopathic thrombocytopenic purpura (ITP) who, under treatment with immunosuppressive drugs, developed bilateral interstitial pulmonary disease. Previously she had been splenectomized and treated with corticosteroids and cyclosporin. During the clinical course, the patient developed alterations of the hepatogram and presented a positive serology for Epstein-Barr virus. The lung biopsy showed the histologic pattern of obliterative bronchiolitis, interstitial inflammatory infiltration and intraalveolar pneumonia (BOOP). We could not find in the literature a previous report in which ITP was associated with BOOP. Of interest was the spontaneous remission of the pulmonary disease after suppression of cyclosporin and positive serology for Epstein-Barr virus.
Subject(s)
Cryptogenic Organizing Pneumonia/complications , Purpura, Thrombocytopenic, Idiopathic/complications , Adult , Cryptogenic Organizing Pneumonia/diagnosis , Female , HumansSubject(s)
Gangliosides/pharmacology , Polyradiculoneuropathy/chemically induced , Humans , Male , Middle AgedSubject(s)
Humans , Male , Adult , HIV Infections/complications , Acquired Immunodeficiency Syndrome/complications , Purpura, Thrombotic Thrombocytopenic/etiology , Purpura, Thrombotic Thrombocytopenic/drug therapy , Purpura, Thrombotic Thrombocytopenic/blood , Plasmapheresis/standards , HIV Infections/drug therapySubject(s)
Humans , Male , Adult , HIV Infections/complications , Purpura, Thrombotic Thrombocytopenic/etiology , Acquired Immunodeficiency Syndrome/complications , HIV Infections/drug therapy , Plasmapheresis/standards , Purpura, Thrombotic Thrombocytopenic/drug therapy , Purpura, Thrombotic Thrombocytopenic/bloodSubject(s)
Humans , Male , Paraplegia/etiology , Syringomyelia/etiology , Tuberculosis, Pulmonary/complications , Acute Disease , Adult , Antitubercular Agents/therapeutic use , Drug Therapy, Combination , English Abstract , Paraplegia/diagnosis , Paraplegia/drug therapy , Syringomyelia/diagnosis , Syringomyelia/drug therapy , Treatment Refusal , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapySubject(s)
Humans , Male , Paraplegia/etiology , Syringomyelia/etiology , Tuberculosis, Pulmonary/complications , Acute Disease , Adult , Antitubercular Agents/therapeutic use , Drug Therapy, Combination , English Abstract , Paraplegia/diagnosis , Paraplegia/drug therapy , Syringomyelia/diagnosis , Syringomyelia/drug therapy , Treatment Refusal , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapyABSTRACT
This 42-year-old male patient voluntarily discontinued treatment for lung TBC and twenty days later developed acute paraplegia. Magnetic resonance imaging (MRI) demonstrated a large intramedullary cavity extending from T2 to the conus medullaris. Having resumed anti-TBC treatment, the patient progressed favourably, despite any change in cavity size. Tuberculous meningitis may be complicated by the appearance of intramedullary cavities by two distinct mechanisms: 1) adhesive arachnoiditis at the skull base with obstruction of Luschka and Magendie foramina, followed by hydrocephalus and hydromyelia; and 2) spinal cord arachnoiditis with the development of arachnoidal and intramedullary cysts. In either case, symptoms are of late presentation. To the best of our knowledge, this is the first report in the literature of lung tuberculosis associated with syringomyelia but without basal arachnoiditis. Acute clinical presentation with paraplegia is exceptional.
Subject(s)
Paraplegia/etiology , Syringomyelia/etiology , Tuberculosis, Pulmonary/complications , Acute Disease , Adult , Antitubercular Agents/therapeutic use , Drug Therapy, Combination , Humans , Male , Paraplegia/diagnosis , Paraplegia/drug therapy , Syringomyelia/diagnosis , Syringomyelia/drug therapy , Treatment Refusal , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapyABSTRACT
This 42-year-old male patient voluntarily discontinued treatment for lung TBC and twenty days later developed acute paraplegia. Magnetic resonance imaging (MRI) demonstrated a large intramedullary cavity extending from T2 to the conus medullaris. Having resumed anti-TBC treatment, the patient progressed favourably, despite any change in cavity size. Tuberculous meningitis may be complicated by the appearance of intramedullary cavities by two distinct mechanisms: 1) adhesive arachnoiditis at the skull base with obstruction of Luschka and Magendie foramina, followed by hydrocephalus and hydromyelia; and 2) spinal cord arachnoiditis with the development of arachnoidal and intramedullary cysts. In either case, symptoms are of late presentation. To the best of our knowledge, this is the first report in the literature of lung tuberculosis associated with syringomyelia but without basal arachnoiditis. Acute clinical presentation with paraplegia is exceptional.
ABSTRACT
This 42-year-old male patient voluntarily discontinued treatment for lung TBC and twenty days later developed acute paraplegia. Magnetic resonance imaging (MRI) demonstrated a large intramedullary cavity extending from T2 to the conus medullaris. Having resumed anti-TBC treatment, the patient progressed favourably, despite any change in cavity size. Tuberculous meningitis may be complicated by the appearance of intramedullary cavities by two distinct mechanisms: 1) adhesive arachnoiditis at the skull base with obstruction of Luschka and Magendie foramina, followed by hydrocephalus and hydromyelia; and 2) spinal cord arachnoiditis with the development of arachnoidal and intramedullary cysts. In either case, symptoms are of late presentation. To the best of our knowledge, this is the first report in the literature of lung tuberculosis associated with syringomyelia but without basal arachnoiditis. Acute clinical presentation with paraplegia is exceptional.